Have a personal or library account? Click to login
Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials Cover

Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials

Open Access
|Oct 2021

Authors

Syed Wasif Gillani

dr.syedwasif@gmu.ac.ae

Department of Pharmacy Practice, College of Pharmacy Gulf Medical University, Ajman, United Arab Emirates

Anam Azhar

Pharm D candidates, College of Pharmacy Gulf Medical University, Ajman, United Arab Emirates

Shabaz Mohiuddin Gulam

Department of Pharmacy Practice, College of Pharmacy Gulf Medical University, Ajman, United Arab Emirates

Fithawit Bahran Gebreigziabher

Department of Pharmacy Practice, College of Pharmacy Gulf Medical University, Ajman, United Arab Emirates

Hassaan Anwer Rathore

College of Pharmacy, Qatar University, Doha, Qatar
DOI: https://doi.org/10.2478/cipms-2021-0024 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 123 - 129
Submitted on: Jan 6, 2021
|
Accepted on: Jun 12, 2021
|
Published on: Oct 8, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Syed Wasif Gillani, Anam Azhar, Shabaz Mohiuddin Gulam, Fithawit Bahran Gebreigziabher, Hassaan Anwer Rathore, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.